Luye Pharma Group Ltd. (2186.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 9.59B |
| Enterprise Value | 14.51B |
| P/E Ratio | 11.62 |
| PEG Ratio | 0.35 |
| Price/Sales Ratio | 1.17 |
| Price/Book Ratio | 0.46 |
| Enterprise/Revenue | 1.95 |
| Enterprise/EBITDA | 6.53 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0.1 |
| Operating Margin | 0.2 |
AD
Management Effectiveness
| Return On Assets | 0.02 |
| Return On Equity | 0.04 |
Income Statement
| Revenue | 6.31B |
| Revenue/Share | 1.56 |
| Gross Profit | 4.16B |
| EBITDA | 2.01B |
| Net Income | 618.75M |
| Diluted EPS | 0.16 |
Balance Sheet
| Total Cash | 8.88B |
| Total Cash/Share | 2.2 |
| Total Debt | 9.42B |
| Total Debt/Equity | 0.59 |
| Current Ratio | 1.53 |
| Book Value Per Share | 4.63 |
Price History
| 52-Week Change | -42.71 |
| 52-Week High | 3.94 |
| 52-Week Low | 1.73 |
| Moving Average 50 Days | 2.01 |
| Moving Average 200 Days | 2.53 |
Statistics
| Average Volume | 43.91M |
| Shares Outstanding | 3.99B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
